Searched for
SENORES PHARMA BUSINESS OVERVIEW
Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...- India has wide AI talent gaps in deployment, governance, security: Quess reportIndia faces significant AI talent gaps in deployment, governance, and security roles, with GenAI deployment showing the widest deficit. Whi...
- Business quote of the day by Google CEO Sundar Pichai: “As a leader, it is important to not just see your own success, but focus on the success of others” What business owners can learn from Sundar Pichai's mindsetGoogle CEO Sundar Pichai emphasizes that leaders must focus on others' success. True leadership means helping teams grow and reach their po...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- ICAI CA Intermediate Result 2026 Date & Time: How to download your scorecard at icai.orgThe Institute of Chartered Accountants of India will release CA Intermediate May 2026 results on June 24, 2026. Students can check their sc...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- NBFCs and private banks better positioned than PSU banks: Aman ChowhanAman Chowhan of Abakkus Asset Manager highlights crude oil as the dominant macro risk, potentially impacting corporate earnings by 100-200 ...
- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Light at the end of the tunnel? Gautam Shah sees Nifty eyeing 25,500, bets on smallcaps, pharma and Adani stocksIndian equities are nearing a crucial turning point, with market veteran Gautam Shah suggesting a shift in focus beyond benchmark indices. ...
- Business lesson from Amazon CEO Jeff Bezos: "Make employees think like owners" What business owners can learn from billionaire's success mindsetAmazon founder Jeff Bezos emphasized fostering an ownership mindset among employees to drive success. By aligning employee interests with l...
- Travelling to Germany for work meetings? Here's the visa processGermany is a key European hub for international business, requiring a short-stay Schengen visa for non-visa-exempt nationals visiting for u...
- AI is everywhere. But which products are truly transforming business?The next wave of business transformation is being driven by AI products that deliver measurable results. The ET Most Innovative AI Product ...
- Business lesson from world's first trillionaire Elon Musk: 'Rely less on business gurus and their books and more on biographies' What business owners can learn from world's richest man's success mindsetElon Musk, the world's first trillionaire, eschews traditional business gurus, drawing wisdom from history and biographies of innovators. H...
- Google to appeal German court ruling assigning liability for AI Overviews false claimsGoogle will challenge a German court's decision. The court found the tech giant directly responsible for incorrect information in its AI Ov...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- 'Time to cherry pick again': Porinju Veliyath says small and midcaps have bottomed & Thomas Cook is his latest buyPorinju Veliyath sees the correction in small and midcap stocks ending. He believes patient investors will find rewards. Thomas Cook India ...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Google must let UK publishers opt out of AI search under new rulesBritain's competition watchdog has introduced new rules for Google's search. Publishers can now decide if their content powers Google's AI....
Load More
